Does Spinal Cord Stimulation Have an Effect Beyond Patients' Expectations? An Investigation of Treatment and Placebo Effects
Does Spinal Cord Stimulation (SCS) Have an Effect Beyond Patients' Expectations? An Investigation of Treatment and Placebo Effects
2 other identifiers
interventional
25
1 country
1
Brief Summary
The aim of the study is to evaluate treatment outcomes of Spinal Cord Stimulation. In the study each patient participates in four test sessions of 4-5 hours. Patients arrive for test days with their stimulation on. In each test session, baseline pain is first evaluated. Then, SCS is regulated (on/off) and patients evaluate their pain intensity immidiately and every 15 minutes during the test sessions. Patients are blinded to the treatment conditions during their participation in the study. At all times, patients can resume their usual treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 19, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2027
January 9, 2026
September 1, 2025
2.8 years
September 19, 2025
January 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients' subjective pain intensity evaluated on a 0-10 Mechanical Visual Analogue Scale (M-VAS)
From enrollment to completion of four test sessions scheduled with a minimum interval of one week between each session.
Study Arms (4)
Placebo condition
PLACEBO COMPARATORThe patient is incorrectly told that stimulation is on
Total treatment
ACTIVE COMPARATORThe patient is correctly told that stimulation is on
Stimulation treatment
OTHERThe patient is incorrectly told that stimulation is off
Control condition
OTHERThe patient is correctly told that stimulation is off
Interventions
Eligibility Criteria
You may qualify if:
- Patients (\>18 years of age) with SCS implanted to treat chronic pain.
- Patients who consent to participation and can cooperate in the study.
- Use of continuous paresthesia-free SCS for minimum 6 months prior to participation in the study.
- Patients not receiving other neuromodulation treatment.
- Patients who have not undergone changes in their (pain relevant) medication during the last 30 days (pro necessitate medication allowed).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University Hospital
Aarhus N, 8200, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postdoc
Study Record Dates
First Submitted
September 19, 2025
First Posted
January 9, 2026
Study Start
September 1, 2024
Primary Completion (Estimated)
July 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
January 9, 2026
Record last verified: 2025-09